http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2463043-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b08822eef3ba733424894f5e8c080ce7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate | 2011-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b65d905b0e45ad271060e7c486c375e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86d8953b988d065afadeba2ac5a20917 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87e0c4c21ad4ebdc54b8f7990dbb5720 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_724d62b0ebc0d9f3150413501980903e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca195f01d8de07d0782ef0fbe132527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92d5197d79fcff1eeafcf8ea86ad1931 |
| publicationDate | 2012-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2463043-C1 |
| titleOfInvention | Method of increasing efficiency of short-term and middle-term antihypertensive therapy and reduction of left ventrucle hypertrophy in patients with arterial hypertension of 2-nd phase of 2-nd degree of risk 3 |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to cardiology and deals with increase of antihypertensive therapy efficiency and reduction of left ventricle hypertrophy in patients with arterial hypertension of 2-nd degree with high risk of development of cardio-vascular complications (risk 3). For this purpose antihypertensive therapy is performed taking into account prevailing temperament or prevailing part of vegetative nervous system, as well as personality anxiety. With account of said factors elaborated are versions of complex therapy, namely: a) beta-adrenoreceptor antagonist (BAA) and diuretic in average day dose in combination with anxiolytic in minimal day dose; b) BAA and diuteric in minimal day dose; c) ACE inhibitor and diuretic in average day dose in combination with antidepressant in minimal day dose; d) ACE inhibitor and diuretic in minimal day dose and antidepressant in minimal day dose. n EFFECT: method ensures efficient treatment of arterial hyopertension and prevention of acute disorders in blood circulation system due to differentiated administration of drug therapy taking into account psychoemotional background in said group of patients. n 5 ex, 23 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2762909-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2596497-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2632449-C1 |
| priorityDate | 2011-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 177.